Revolutionizing LNP & nanoparticle manufacturing
Revolutionizing nanoparticle manufacturing
Our mission is to provide you with the right tools to ensure seamless scalability all along your nanoparticle-based drug development process and unlock the full potential of the RNA-LNP vaccines and therapeutics
Discover TAMARA
The most accessible nanoparticle synthesis platform for the formulation of RNA-LNP, liposomes, SLN, PLGA nanoparticles...
Quick and easy to use
Run your experiment in less than 10 secondes: pipette in your solution, plug-in your chip, select your synthesis conditions and press on play
From µL to mL
Use the same system from your discovery stage to your in vivo testings and accelerate the validation of your drug product
Reusable chips
Clean your chips between runs to prevent batch-to-batch cross-contaminations.
Ultimate nanoparticle characteristics control
Benefit from the most advanced microfluidics technology for best size control (50-200 nm), PDI (<0.2), EE% (>95%) and repeatability (5%)
100% material use
Thanks to the optimized liquid circuit, work with small volumes (100µL) with no waste of expensive sample
Accelerating your screening to production time with our nanoparticle synthesis solutions
Quick and easy to use
Run your experiment in less than 10 secondes: pipette in your solution, plug-in your chip, select your synthesis conditions and press on play
From µL to mL
Use the same system from your discovery stage to your in vivo testings and accelerate the validation of your drug product
100% material use
Thanks to the optimized liquid circuit, work with small volumes (100µL) with no waste of expensive sample
Contamination-free
Benefit from cleanable chips to prevent batch to batch cross-contaminations.
Screen your formulations with no ingredient waste thanks to an unprecedented technology
Scale-up to clinical studies, from microliters to liters, using the same formulation technology
They trust our technology
The uniqueness of Inside Therapeutics solution is that it allows for the straightforward synthesis of nanoparticles at very small volumes, making it easy and cost-efficient to use for screening and small batch production. The use of Inside Tx's solution has helped OSE immunotherapeutics to rapidly gain robust knowledge in the LNP synthesis in a short period of time. The team at Inside Tx was very helpful in implementing solutions well-adapted for our purposes